Bilateral Acute Iris Transillumination (BAIT): A Rare Syndrome Possibly Associated with COVID-19 and Moxifloxacin Use. A Report of 2 Cases.
Semin Ophthalmol
; 38(3): 312-315, 2023 Apr.
Article
in English
| MEDLINE | ID: covidwho-2187119
ABSTRACT
Bilateral acute iris transillumination (BAIT) is a rare clinical entity, presumed to be associated with preceding upper respiratory tract infection and/or use of certain antibiotics, marked by bilateral acute loss of iris pigment epithelium with pigment dispersion in the anterior chamber and trabecular meshwork, which can cause elevated intraocular pressure and glaucoma, and with iris transillumination and sphincter paralysis which lead to photophobia and blurry vision. We report the first two cases of BAIT in our center which both had a history of preceding COVID-19 (coronavirus disease 2019) and moxifloxacin use. With more awareness, ophthalmologists might diagnose more cases, and thus gain more information regarding the link between COVID-19 and BAIT, which might be underdiagnosed since it is rare or easily misdiagnosed as some more common diseases with similar features.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Glaucoma
/
COVID-19
/
Iris Diseases
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Semin Ophthalmol
Journal subject:
Ophthalmology
Year:
2023
Document Type:
Article
Affiliation country:
08820538.2023.2168491
Similar
MEDLINE
...
LILACS
LIS